Acute lung injury in patients with COVID-19 infection
- PMID: 32508022
- PMCID: PMC7240840
- DOI: 10.1002/ctm2.16
Acute lung injury in patients with COVID-19 infection
Abstract
During the 2020 Spring Festival in China, the outbreak of a novel coronavirus, named COVID-19 by WHO, brought on a worldwide panic. According to the clinical data of infected patients, radiologic evidence of lung edema is common and deserves clinical attention. Lung edema is a manifestation of acute lung injury (ALI) and may progress to hypoxemia and potentially acute respiratory distress syndrome (ARDS). Patients diagnosed with ARDS have poorer prognosis and potentially higher mortality. Although no effective treatment is formally approved for COVID-19 infection, support of ventilation with oxygen therapy and sometimes mechanical ventilation is often required. Treatment with systemic and/or local glucocorticoids might be helpful to alleviate the pulmonary inflammation and edema, which may decrease the development and/or consequences of ARDS. In this article, we focus on the lung edema and ALI of patients with this widely transmitted COVID-19 infection in order to provide clinical indications and potential therapeutic targets for clinicians and researchers.
Keywords: ARDS; COVID-19; lung edema.
© 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome.J Control Release. 2023 Aug;360:1-14. doi: 10.1016/j.jconrel.2023.06.018. Epub 2023 Jun 19. J Control Release. 2023. PMID: 37330013 Review.
-
Evaluation of Pulmonary Edema Using Ultrasound Imaging in Patients With COVID-19 Pneumonia Based on a Non-local Channel Attention ResNet.Ultrasound Med Biol. 2022 May;48(5):945-953. doi: 10.1016/j.ultrasmedbio.2022.01.023. Epub 2022 Feb 7. Ultrasound Med Biol. 2022. PMID: 35277285 Free PMC article.
-
The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective multicenter study on the quantitative differential diagnostic definition for acute lung injury/acute respiratory distress syndrome.Crit Care. 2012 Dec 11;16(6):R232. doi: 10.1186/cc11898. Crit Care. 2012. PMID: 23232188 Free PMC article.
-
Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.Chest. 2009 Jun;135(6):1440-1447. doi: 10.1378/chest.08-2465. Epub 2009 Feb 2. Chest. 2009. PMID: 19188556 Free PMC article.
-
Macrophage-Targeted Nanomedicines for ARDS/ALI: Promise and Potential.Inflammation. 2022 Dec;45(6):2124-2141. doi: 10.1007/s10753-022-01692-3. Epub 2022 May 31. Inflammation. 2022. PMID: 35641717 Free PMC article. Review.
Cited by
-
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages.Sci Transl Med. 2021 Jun 2;13(596):eabf8654. doi: 10.1126/scitranslmed.abf8654. Epub 2021 May 11. Sci Transl Med. 2021. PMID: 33979301 Free PMC article.
-
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure.mSystems. 2021 Oct 26;6(5):e0009521. doi: 10.1128/mSystems.00095-21. Epub 2021 Oct 26. mSystems. 2021. PMID: 34698547 Free PMC article.
-
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?Mol Biomed. 2021 Nov 23;2:38. doi: 10.1186/s43556-021-00060-1. eCollection 2021 Dec. Mol Biomed. 2021. PMID: 34841263 Free PMC article. Review.
-
Multiple relationships between aerosol and COVID-19: A framework for global studies.Gondwana Res. 2021 May;93:243-251. doi: 10.1016/j.gr.2021.02.002. Epub 2021 Feb 9. Gondwana Res. 2021. PMID: 33584115 Free PMC article.
-
The Effects of Hospitalisation on the Serum Metabolome in COVID-19 Patients.Metabolites. 2023 Aug 16;13(8):951. doi: 10.3390/metabo13080951. Metabolites. 2023. PMID: 37623894 Free PMC article.
References
Grants and funding
- Operation funding of Shanghai Institute of Clinical Bioinformatics and Shanghai Engineering and Technology Center for Artificial Intelligence of Lung and Heart Diseases from Zhongshan Hospital
- 81873409/The National Nature Science Foundation of China
- 2017YFC0909500/National Key Research and Development Program of Precision Medicine
LinkOut - more resources
Full Text Sources